Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffery W Kelly

Showing results (1-10 of 330) with videos related to

Pageof 33
Sort By:
Cold Spring Harbor Perspectives in Biology|May 16, 2019
Pharmacologic Approaches for Adapting Proteostasis in the Secretory Pathway to Ameliorate Protein Conformational DiseasesJeffery W Kelly
Blood|December 17, 2011
Finally, a transgenic light chain amyloidosis mouse modelJeffery W Kelly
Elife|July 11, 2018
The two shapes of the Tau proteinJeffery W Kelly
The New England Journal of Medicine|February 18, 2005
Attacking amyloidJeffery W Kelly
Nature|July 21, 2006
Structural biology: proteins downhill all the wayJeffery W Kelly
Cardiology and Therapy|July 29, 2025
Transthyretin Kinetic Stabilizers for ATTR AmyloidosisJeffery W Kelly
Nature|September 24, 2005
Structural biology: form and function instructionsJeffery W Kelly
Science Translational Medicine|January 21, 2021
Does protein aggregation drive postmitotic tissue degeneration?Jeffery W Kelly
Biochemistry|July 23, 2003
Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditionsQinghai Zhang, Jeffery W Kelly
Science (New York, N.Y.)|July 28, 2007
Medicine. The yin-yang of sirtuinsAndrew Dillin, Jeffery W Kelly
Pageof 33

Showing results (1-10 of 330) with videos related to

Sort By:
Pageof 33
Cold Spring Harbor Perspectives in Biology|May 16, 2019
Pharmacologic Approaches for Adapting Proteostasis in the Secretory Pathway to Ameliorate Protein Conformational DiseasesJeffery W Kelly
Blood|December 17, 2011
Finally, a transgenic light chain amyloidosis mouse modelJeffery W Kelly
Elife|July 11, 2018
The two shapes of the Tau proteinJeffery W Kelly
The New England Journal of Medicine|February 18, 2005
Attacking amyloidJeffery W Kelly
Nature|July 21, 2006
Structural biology: proteins downhill all the wayJeffery W Kelly
Cardiology and Therapy|July 29, 2025
Transthyretin Kinetic Stabilizers for ATTR AmyloidosisJeffery W Kelly
Nature|September 24, 2005
Structural biology: form and function instructionsJeffery W Kelly
Science Translational Medicine|January 21, 2021
Does protein aggregation drive postmitotic tissue degeneration?Jeffery W Kelly
Biochemistry|July 23, 2003
Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditionsQinghai Zhang, Jeffery W Kelly
Science (New York, N.Y.)|July 28, 2007
Medicine. The yin-yang of sirtuinsAndrew Dillin, Jeffery W Kelly
Pageof 33